TAIPEI, TAIWAN / ACCESSWIRE / December 4, 2023 / Helo Corp. (OTC PINK:HLOC) ("Helo" or the "Company"), a data-driven wellness technology company leading the development of wearable and other biodata gathering devices, and artificial intelligence (AI) to drive human wellness transformation, recently announced its NutraMatic™ at a product event in Taipei, Taiwan.
"We were delighted to announce the genesis of our revolutionary NutraMatic at a recent event in Taiwan," said Fabio Galdi, Chief Visionary Officer. "Our patent-pending NutraMatic represents the latest advancement of our Helo® AI platform, allowing us to provide precision supplements to our customers in their home, in real-time and based on their prevailing biodata. Our technology team is developIng a solution that delivers dynamic AI-generated performance feedback with individualized lifestyle and wellness recommendations. Each user's experience will be unique to them, as the platform will detect changes in a user's biodata and direct NutraMatic to update their supplement combination accordingly, while their app updates their wellness recommendations."
Helo AI is an innovative, easy-to-use consumer platform designed to support wellness improvement and will provide AI-generated, and app-delivered personalized wellness recommendations based on individual user biodata. This biodata is generated by Helo products featuring Life Sensing TechnologyTM, including its recently launched BioStripTM, award-winning BioSense health bandTM and other wearables and connected wellness technology devices. NutraMatic is a countertop device designed to provide users with their AI-optimized and personalized combination of nutrition supplements, based on their current biodata status.
"NutraMatic allows us to challenge players that supply the same supplements to everyone, regardless of their state of wellness, nutritional needs or activity levels," said Sean McVeigh, Chief Executive Officer. "Not only will NutraMatic provide turnkey precision supplements to customers worldwide, our Helo AI recommendation engine encourages a healthier lifestyle by providing individualized and timely feedback, which supports personal wellness improvement and customer loyalty. As NutraMatic is IoT connected, user supplement consumption will be monitored to enable an auto ship supplement subscription model. We anticipate strong demand for NutraMatic, which we expect will be available to ship in the second quarter of 2024. In the meantime, we plan to continue our international investigational study to train our Helo AI knowledge domain and provide an even more personalized solution to our customers," continued McVeigh.
The Helo management team has been invited to participate in the Emerging Growth Conference on Wednesday, December 6, 2023, at 10:15 a.m. ET. During the call, management plans to discuss upcoming business initiatives, including its refocused strategic direction and planned product launch. Please register here to attend the conference, or view the archived webcast on EmergingGrowth.com or on the Emerging Growth YouTube Channel.
About Helo Corp.
Helo Corp. (OTC:HLOC) is a data-driven wellness technology company. Helo wearables and other smart devices are built on Helo's Life Sensing Technology®, which uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters. Helo is developing the Helo AI platform to leverage artificial intelligence and other technologies to analyze wearer data to provide recommendations that support the adoption of healthier lifestyle choices to drive human wellness transformation.
For more information please visit helocorp.com and nutralife.ai.
The Company's disclosure statements and financial statements are available at OTC:HLOC.
Forward Looking Statements
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expect," "anticipate," "plan," and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Investors Contact:
[email protected]
+ 1 650-646-2193
SOURCE: Helo Corp.